Glaxo ratchets up advertising as sales of weight loss pill alli fall after FDA safety probeGlaxo defends safety of weight loss drug alli WASHINGTON — British drugmaker GlaxoSmithKline is scrambling to shore up the safety image of its weight loss pill alli, after watching sales dive on news that federal regulators are investigating the drug. Studies show 1 dose of swine flu vaccine works for adults, good news for busy flu seasonStudies: 1 dose of swine flu vaccine works WASHINGTON — Good news in the world’s flu fight: One dose of the new swine flu vaccine looks strong enough to protect adults — and can spark protection within 10 days of the shot, Australian and U.S. researchers said Thursday. Glaxo’s Cervarix vaccine moves towards US approval, Merck’s Gardasil wins backing for boysFDA panel backs Glaxo’s cervical vaccine for women WASHINGTON — Federal health officials said Wednesday a long-delayed vaccine from GlaxoSmithKline successfully blocks the leading virus that causes cervical cancer in women. FDA says Glaxo vaccine to prevent cervical cancer is safe, effectiveFDA backs Glaxo’s vaccine Cervarix for women WASHINGTON — Federal health officials said Wednesday a long-delayed vaccine from GlaxoSmithKline successfully blocks the leading virus that causes cervical cancer in women. Health care workers under more pressure to get vaccinated against flu; half of them skip shotsHealth workers under pressure to get flu shots ALBANY, N.Y. — Tens of thousands of health care workers who typically avoid flu shots are under more pressure than ever to get vaccinated as hospitals and clinics prepare for a spike in swine flu cases this fall and winter. Washington State official says college swine flu outbreak may be waning; at least 2,200 sickSwine flu outbreak at Washington St. may be easing PULLMAN, Wash. — A swine flu outbreak at Washington State University that is suspected of sickening more at least 2,200 students may be tapering off, a campus health official said Monday. FDA says Glaxo vaccine prevents cervical cancer; competitor Merck seeks approval for boysGlaxo’s cancer vaccine inches toward approval WASHINGTON — Federal regulators said Friday that a GlaxoSmithKline vaccine prevents the leading cause of cervical cancer in women, bringing the company one step closer to competing with Merck’s blockbuster Gardasil, which has controlled the U.S. market for three years. Dainippon Sumitomo Pharma of Japan acquiring US drug maker Sepracor for $2.6 billionDainippon of Japan acquires US drug maker Sepracor TOKYO — Japanese drug company Dainippon Sumitomo Pharma Co. is acquiring U.S. drug maker Sepracor Inc. for about $2.6 billion in an effort to expand in the U.S. market, both sides said Thursday. Research shows statin use reduces heart attacks, deaths after surgery on blood vesselsStatin cuts heart problems after artery surgery NEW YORK — Score another victory for the cheap, cholesterol-lowering wonder drugs known as statins. People getting an artery unclogged or repaired were much less likely to die or have a heart attack afterward if they took preventive doses of the pills before and after their operations, a Dutch study showed. Analyst says MAP Pharma will rise when more details on migraine drug are reported next weekAnalyst says new Levadex data could lift MAP stock NEW YORK — MAP Pharmaceuticals Inc. plans to share additional data from testing of its migraine drug candidate Levadex next week, and a Wedbush Morgan analyst said the results could boost MAP’s share price. Danaher buying MDS, Life Technologies unit for $1.1 billion; 3,300 jobs, 30 plants to be shedDanaher buying MDS, Life Technologies unit NEW YORK — Danaher Corp., widely known for its Craftsman hand tools, on Wednesday unveiled a strategic expansion of its medical technology and professional instrumentation business, even as it shrinks other operations. Pfizer paying record $2.3B settlement for illegal promotions of 4 prescription drugsPfizer to pay record $2.3B penalty over promotions WASHINGTON — Pfizer Inc., the world’s largest drug maker, will pay a record $2.3 billion civil and criminal penalty over unlawful prescription drug promotions, the Justice Department announced Wednesday. Acadia Pharmaceuticals shares plunge as Parkinson’s disease drug fails late-stage studyAcadia shares fall on failed Parkinson’s study NEW YORK — Shares of Acadia Pharmaceuticals Inc. plunged Tuesday after the company said its drug candidate pimavanserin failed to meet key treatment goals in a late-stage study focusing on patients with Parkinson’s disease psychosis. Merck to structure itself into 5 units following close of $41.1 billion Schering-Plough dealMerck to form 5 divisions after Schering buyout NEW YORK — Richard T. Clark, current president and CEO of Merck, said Monday the company will restructure into five divisions after it completes its buyout of rival Schering-Plough for $41.1 billion. |
Latest TweetsHealth Care Industry
Latest Friend FeedsHealth Care Industry
|
